Again With the Bats? Strauss Had It Right: “Die, Fledermaus!”

Must read

Saudi National Bank to lose $1.2B on Credit Suisse rescue

Saudi National Bank chairman Ammar Al Khudairy’s comments last week may end up being one of the most expensive answers delivered on television. ...

Credit Suisse failure follows years of scandal and mistrust—with an Ohio mattress company playing a role

Credit Suisse Group AG, once one of the stalwarts of the global financial system, is no more.  After tense talks over...

UBS on Credit Suisse takeover: ‘We will be de-risking a lot of the tricky businesses that we are inheriting’

UBS Group AG Chairman Colm Kelleher said he will manage down Credit Suisse Group AG’s investment bank, curtailing a source of losses in recent...

New York Community Bancorp looks to acquire failed Signature Bank

New York Community Bancorp is pursuing a deal to acquire failed Signature Bank, according to people familiar with the matter.  The...

From Euronews: “Khosta-2: Scientists warn Russian bat virus could infect humans and resist COVID vaccines.” It cites to PLOS Pathogens:

An ACE2-dependent Sarbecovirus in Russian bats is resistant to SARS-CoV-2 vaccines

Spillover of sarbecoviruses from animals to humans has resulted in outbreaks of severe acute respiratory syndrome SARS-CoVs and the ongoing COVID-19 pandemic. Efforts to identify the origins of SARS-CoV-1 and -2 has resulted in the discovery of numerous animal sarbecoviruses–the majority of which are only distantly related to known human pathogens and do not infect human cells. The receptor binding domain (RBD) on sarbecoviruses engages receptor molecules on the host cell and mediates cell invasion. Here, we tested the receptor tropism and serological cross reactivity for RBDs from two sarbecoviruses found in Russian horseshoe bats. While these two viruses are in a viral lineage distinct from SARS-CoV-1 and -2, the RBD from one virus, Khosta 2, was capable of using human ACE2 to facilitate cell entry. Viral pseudotypes with a recombinant, SARS-CoV-2 spike encoding for the Khosta 2 RBD were resistant to both SARS-CoV-2 monoclonal antibodies and serum from individuals vaccinated for SARS-CoV-2. Our findings further demonstrate that sarbecoviruses circulating in wildlife outside of Asia also pose a threat to global health and ongoing vaccine campaigns against SARS-CoV-2[.]

More articles

Latest article

Saudi National Bank to lose $1.2B on Credit Suisse rescue

Saudi National Bank chairman Ammar Al Khudairy’s comments last week may end up being one of the most expensive answers delivered on television. ...

Credit Suisse failure follows years of scandal and mistrust—with an Ohio mattress company playing a role

Credit Suisse Group AG, once one of the stalwarts of the global financial system, is no more.  After tense talks over...

UBS on Credit Suisse takeover: ‘We will be de-risking a lot of the tricky businesses that we are inheriting’

UBS Group AG Chairman Colm Kelleher said he will manage down Credit Suisse Group AG’s investment bank, curtailing a source of losses in recent...

New York Community Bancorp looks to acquire failed Signature Bank

New York Community Bancorp is pursuing a deal to acquire failed Signature Bank, according to people familiar with the matter.  The...

Credit Suisse’s $17B of risky bonds now worthless after takeover by UBS: ‘Those bonds were created for moments like this’

Holders of Credit Suisse Group AG bonds suffered a historic loss when a takeover by UBS Group AG wiped out about 16 billion Swiss...